ondansetron
Generic: ondansetron
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
ondansetron
Generic Name
ondansetron
Labeler
bryant ranch prepack
Dosage Form
TABLET, ORALLY DISINTEGRATING
Routes
Active Ingredients
ondansetron 8 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71335-2973
Product ID
71335-2973_0d752116-b9e4-4ee6-a395-0e4a83f892dc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209389
Listing Expiration
2026-12-31
Marketing Start
2025-06-19
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
713352973
Hyphenated Format
71335-2973
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ondansetron (source: ndc)
Generic Name
ondansetron (source: ndc)
Application Number
ANDA209389 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 8 mg/1
Packaging
- 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-1)
- 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-2)
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-3)
- 14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-4)
- 12 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-5)
- 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-6)
Packages (6)
71335-2973-1
90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-1)
71335-2973-2
60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-2)
71335-2973-3
30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-3)
71335-2973-4
14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-4)
71335-2973-5
12 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-5)
71335-2973-6
10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-6)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0d752116-b9e4-4ee6-a395-0e4a83f892dc", "openfda": {"nui": ["N0000175817", "N0000175818"], "unii": ["4AF302ESOS"], "rxcui": ["312087"], "spl_set_id": ["7949c245-b79f-4eaf-a75f-9a17bd7bd307"], "pharm_class_epc": ["Serotonin-3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Serotonin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-1)", "package_ndc": "71335-2973-1", "marketing_start_date": "20251106"}, {"sample": false, "description": "60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-2)", "package_ndc": "71335-2973-2", "marketing_start_date": "20251106"}, {"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-3)", "package_ndc": "71335-2973-3", "marketing_start_date": "20251106"}, {"sample": false, "description": "14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-4)", "package_ndc": "71335-2973-4", "marketing_start_date": "20251106"}, {"sample": false, "description": "12 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-5)", "package_ndc": "71335-2973-5", "marketing_start_date": "20251106"}, {"sample": false, "description": "10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-6)", "package_ndc": "71335-2973-6", "marketing_start_date": "20251106"}], "brand_name": "Ondansetron", "product_id": "71335-2973_0d752116-b9e4-4ee6-a395-0e4a83f892dc", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "71335-2973", "generic_name": "Ondansetron", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ondansetron", "active_ingredients": [{"name": "ONDANSETRON", "strength": "8 mg/1"}], "application_number": "ANDA209389", "marketing_category": "ANDA", "marketing_start_date": "20250619", "listing_expiration_date": "20261231"}